Literature DB >> 10907809

The Ljubljana classification: a practical strategy for the diagnosis of laryngeal precancerous lesions.

N Gale1, V Kambic, L Michaels, A Cardesa, H Hellquist, N Zidar, M Poljak.   

Abstract

There is no internationally accepted classification of epithelial hyperplastic laryngeal lesions (EHLL). The majority of current classifications follow criteria similar to those commonly used for cervical epithelial lesions. However, the different etiology of laryngeal cancer and its particular clinical and histologic features necessitate a grading system more appropriate to this region. The Ljubljana classification of EHLL was devised in 1971 to cater to this requirement. Detailed criteria for histologic grading in this classification were formulated by a working group on EHLL of the European Society of Pathology in 1999. The system recognizes four grades: simple and abnormal hyperplasia are benign categories; atypical hyperplasia ("risky" epithelium) is potentially malignant, and carcinoma in situ actually malignant. The main features by which the proposed grading system differs from other classifications are: 1. the distinction between benign and potentially malignant lesions; 2. the positive separation of carcinoma in situ from atypical hyperplasia; 3. the lack of prognostic significance for any surface keratin layer. The eventual outcome of EHLL patients so graded justifies the proposal for separating the lesions into a benign group, showing malignant transformation in only 0.9% of cases, from a potentially malignant group showing malignant transformation in 11% of cases. For diagnostically difficult cases, supplementary techniques such as those using morphometry, immunohistochemical and molecular biology are advised to improve the accuracy of diagnosis and predictions of their biological behavior.

Entities:  

Mesh:

Year:  2000        PMID: 10907809     DOI: 10.1097/00125480-200007040-00006

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  20 in total

1.  Oral premalignant lesions.

Authors:  Teruo Amagasa
Journal:  Int J Clin Oncol       Date:  2011-01-07       Impact factor: 3.402

Review 2.  [Narrow band imaging for evaluation of laryngeal mucosal lesions].

Authors:  N Davaris; S Voigt-Zimmermann; A Roessner; C Arens
Journal:  HNO       Date:  2017-06       Impact factor: 1.284

Review 3.  Squamous cell carcinoma of the upper aerodigestive tract: dysplasia and select variants.

Authors:  Bruce M Wenig
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

4.  MicroRNA-10a-5p and microRNA-34c-5p in laryngeal epithelial premalignant lesions: differential expression and clinicopathological correlation.

Authors:  Yanping Hu; Honggang Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-30       Impact factor: 2.503

Review 5.  Oral premalignant lesions: from the pathological viewpoint.

Authors:  Toshiyuki Izumo
Journal:  Int J Clin Oncol       Date:  2011-01-14       Impact factor: 3.402

6.  Autofluorescent diagnostics in laryngeal pathology.

Authors:  Nenad Baletic; Zeljko Petrovic; Ivica Pendjer; Hidajet Malicevic
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-09-25       Impact factor: 2.503

7.  Advantages and limitations of the autofluorescent diagnostics of the laryngeal cancer and precancerosis.

Authors:  Nenad Baletic; Hidajet Malicevic; Zeljko Petrovic; Jelena Marinkovic-Eric; Aleksandar Peric
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-12       Impact factor: 2.503

Review 8.  Dysplasia of the upper aerodigestive tract squamous epithelium.

Authors:  Lewis Roy Eversole
Journal:  Head Neck Pathol       Date:  2009-02-22

9.  [Current classification of precursor lesions of oral squamous cell carcinoma principles of the WHO classification 2005].

Authors:  O Driemel; K Hertel; T E Reichert; H Kosmehl
Journal:  Mund Kiefer Gesichtschir       Date:  2006-03

Review 10.  Grading systems in head and neck dysplasia: their prognostic value, weaknesses and utility.

Authors:  Stijn Fleskens; Piet Slootweg
Journal:  Head Neck Oncol       Date:  2009-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.